nodes	percent_of_prediction	percent_of_DWPC	metapath
Orphenadrine—KCNH2—Sunitinib—kidney cancer	0.114	0.199	CbGbCtD
Orphenadrine—CYP3A4—Everolimus—kidney cancer	0.102	0.178	CbGbCtD
Orphenadrine—CYP3A4—Temsirolimus—kidney cancer	0.0692	0.12	CbGbCtD
Orphenadrine—CYP2B6—Sorafenib—kidney cancer	0.0687	0.12	CbGbCtD
Orphenadrine—CYP2B6—Doxorubicin—kidney cancer	0.0417	0.0725	CbGbCtD
Orphenadrine—CYP3A4—Pazopanib—kidney cancer	0.0364	0.0633	CbGbCtD
Orphenadrine—CYP3A4—Erlotinib—kidney cancer	0.0259	0.0452	CbGbCtD
Orphenadrine—CYP3A4—Paclitaxel—kidney cancer	0.0237	0.0413	CbGbCtD
Orphenadrine—CYP3A4—Sorafenib—kidney cancer	0.0211	0.0367	CbGbCtD
Orphenadrine—CYP3A4—Vinblastine—kidney cancer	0.0208	0.0363	CbGbCtD
Orphenadrine—CYP3A4—Vincristine—kidney cancer	0.0205	0.0356	CbGbCtD
Orphenadrine—CYP3A4—Sunitinib—kidney cancer	0.0171	0.0297	CbGbCtD
Orphenadrine—CYP3A4—Doxorubicin—kidney cancer	0.0128	0.0223	CbGbCtD
Orphenadrine—Epigastric discomfort—Everolimus—kidney cancer	0.00691	0.0519	CcSEcCtD
Orphenadrine—Aplastic anaemia—Dactinomycin—kidney cancer	0.0027	0.0203	CcSEcCtD
Orphenadrine—Dimetacrine—ACHE—kidney cancer	0.0025	0.234	CrCbGaD
Orphenadrine—Vision blurred—Pazopanib—kidney cancer	0.00189	0.0142	CcSEcCtD
Orphenadrine—Hallucination—Everolimus—kidney cancer	0.00181	0.0136	CcSEcCtD
Orphenadrine—Anaphylactic shock—Temsirolimus—kidney cancer	0.00174	0.0131	CcSEcCtD
Orphenadrine—Skin disorder—Temsirolimus—kidney cancer	0.00169	0.0127	CcSEcCtD
Orphenadrine—Skin disorder—Pazopanib—kidney cancer	0.00159	0.012	CcSEcCtD
Orphenadrine—Somnolence—Temsirolimus—kidney cancer	0.00155	0.0116	CcSEcCtD
Orphenadrine—Vision blurred—Everolimus—kidney cancer	0.0015	0.0112	CcSEcCtD
Orphenadrine—Constipation—Temsirolimus—kidney cancer	0.00149	0.0112	CcSEcCtD
Orphenadrine—Tremor—Everolimus—kidney cancer	0.00149	0.0112	CcSEcCtD
Orphenadrine—Agitation—Everolimus—kidney cancer	0.00146	0.011	CcSEcCtD
Orphenadrine—Somnolence—Pazopanib—kidney cancer	0.00146	0.011	CcSEcCtD
Orphenadrine—Cyclopentolate—BCHE—kidney cancer	0.00144	0.135	CrCbGaD
Orphenadrine—Palpitations—Everolimus—kidney cancer	0.0014	0.0105	CcSEcCtD
Orphenadrine—Hypersensitivity—Temsirolimus—kidney cancer	0.00128	0.00964	CcSEcCtD
Orphenadrine—Hallucination—Vincristine—kidney cancer	0.00128	0.00963	CcSEcCtD
Orphenadrine—Tachycardia—Everolimus—kidney cancer	0.00126	0.0095	CcSEcCtD
Orphenadrine—Skin disorder—Everolimus—kidney cancer	0.00126	0.00946	CcSEcCtD
Orphenadrine—Asthenia—Temsirolimus—kidney cancer	0.00125	0.00939	CcSEcCtD
Orphenadrine—Pruritus—Temsirolimus—kidney cancer	0.00123	0.00926	CcSEcCtD
Orphenadrine—Skin disorder—Erlotinib—kidney cancer	0.00121	0.00912	CcSEcCtD
Orphenadrine—Asthenia—Pazopanib—kidney cancer	0.00118	0.00885	CcSEcCtD
Orphenadrine—Pruritus—Pazopanib—kidney cancer	0.00116	0.00872	CcSEcCtD
Orphenadrine—Somnolence—Everolimus—kidney cancer	0.00115	0.00865	CcSEcCtD
Orphenadrine—Dizziness—Temsirolimus—kidney cancer	0.00115	0.00865	CcSEcCtD
Orphenadrine—Anaphylactic shock—Sorafenib—kidney cancer	0.00112	0.00845	CcSEcCtD
Orphenadrine—Constipation—Vinblastine—kidney cancer	0.00111	0.00836	CcSEcCtD
Orphenadrine—Constipation—Everolimus—kidney cancer	0.00111	0.00832	CcSEcCtD
Orphenadrine—Vomiting—Temsirolimus—kidney cancer	0.00111	0.00832	CcSEcCtD
Orphenadrine—Skin disorder—Sorafenib—kidney cancer	0.00109	0.00821	CcSEcCtD
Orphenadrine—Headache—Temsirolimus—kidney cancer	0.00109	0.0082	CcSEcCtD
Orphenadrine—Dizziness—Pazopanib—kidney cancer	0.00108	0.00815	CcSEcCtD
Orphenadrine—Feeling abnormal—Vinblastine—kidney cancer	0.00107	0.00805	CcSEcCtD
Orphenadrine—Constipation—Erlotinib—kidney cancer	0.00107	0.00803	CcSEcCtD
Orphenadrine—Feeling abnormal—Everolimus—kidney cancer	0.00107	0.00802	CcSEcCtD
Orphenadrine—Skin disorder—Sunitinib—kidney cancer	0.00105	0.0079	CcSEcCtD
Orphenadrine—Vomiting—Pazopanib—kidney cancer	0.00104	0.00784	CcSEcCtD
Orphenadrine—Nausea—Temsirolimus—kidney cancer	0.00103	0.00777	CcSEcCtD
Orphenadrine—Agitation—Vincristine—kidney cancer	0.00103	0.00774	CcSEcCtD
Orphenadrine—Headache—Pazopanib—kidney cancer	0.00103	0.00772	CcSEcCtD
Orphenadrine—Aplastic anaemia—Doxorubicin—kidney cancer	0.00101	0.0076	CcSEcCtD
Orphenadrine—Nausea—Pazopanib—kidney cancer	0.000975	0.00732	CcSEcCtD
Orphenadrine—Constipation—Sorafenib—kidney cancer	0.000962	0.00723	CcSEcCtD
Orphenadrine—Hypersensitivity—Vinblastine—kidney cancer	0.000958	0.0072	CcSEcCtD
Orphenadrine—Hypersensitivity—Everolimus—kidney cancer	0.000954	0.00717	CcSEcCtD
Orphenadrine—Asthenia—Vinblastine—kidney cancer	0.000933	0.00701	CcSEcCtD
Orphenadrine—Asthenia—Everolimus—kidney cancer	0.000929	0.00698	CcSEcCtD
Orphenadrine—Constipation—Sunitinib—kidney cancer	0.000925	0.00695	CcSEcCtD
Orphenadrine—Pruritus—Everolimus—kidney cancer	0.000916	0.00689	CcSEcCtD
Orphenadrine—Anaphylactic shock—Vincristine—kidney cancer	0.000915	0.00688	CcSEcCtD
Orphenadrine—Asthenia—Erlotinib—kidney cancer	0.000897	0.00674	CcSEcCtD
Orphenadrine—Urticaria—Sorafenib—kidney cancer	0.000893	0.00671	CcSEcCtD
Orphenadrine—Pruritus—Erlotinib—kidney cancer	0.000884	0.00665	CcSEcCtD
Orphenadrine—Tension—Paclitaxel—kidney cancer	0.000874	0.00657	CcSEcCtD
Orphenadrine—Ethopropazine—BCHE—kidney cancer	0.000873	0.0816	CrCbGaD
Orphenadrine—Anaphylactic shock—Gemcitabine—kidney cancer	0.000868	0.00652	CcSEcCtD
Orphenadrine—Dizziness—Vinblastine—kidney cancer	0.00086	0.00646	CcSEcCtD
Orphenadrine—Dizziness—Everolimus—kidney cancer	0.000857	0.00644	CcSEcCtD
Orphenadrine—Feeling abnormal—Dactinomycin—kidney cancer	0.000844	0.00634	CcSEcCtD
Orphenadrine—Skin disorder—Gemcitabine—kidney cancer	0.000843	0.00634	CcSEcCtD
Orphenadrine—Fenoprofen—PTGS1—kidney cancer	0.000842	0.0787	CrCbGaD
Orphenadrine—Vision blurred—Paclitaxel—kidney cancer	0.000839	0.00631	CcSEcCtD
Orphenadrine—Tremor—Paclitaxel—kidney cancer	0.000834	0.00627	CcSEcCtD
Orphenadrine—Hypersensitivity—Sorafenib—kidney cancer	0.000828	0.00623	CcSEcCtD
Orphenadrine—Vomiting—Vinblastine—kidney cancer	0.000827	0.00621	CcSEcCtD
Orphenadrine—Dizziness—Erlotinib—kidney cancer	0.000827	0.00621	CcSEcCtD
Orphenadrine—Vomiting—Everolimus—kidney cancer	0.000824	0.00619	CcSEcCtD
Orphenadrine—Agitation—Paclitaxel—kidney cancer	0.000818	0.00615	CcSEcCtD
Orphenadrine—Toremifene—CYP1A1—kidney cancer	0.000817	0.0763	CrCbGaD
Orphenadrine—Headache—Vinblastine—kidney cancer	0.000815	0.00612	CcSEcCtD
Orphenadrine—Headache—Everolimus—kidney cancer	0.000812	0.0061	CcSEcCtD
Orphenadrine—Asthenia—Sorafenib—kidney cancer	0.000807	0.00606	CcSEcCtD
Orphenadrine—Hypersensitivity—Sunitinib—kidney cancer	0.000797	0.00599	CcSEcCtD
Orphenadrine—Pruritus—Sorafenib—kidney cancer	0.000796	0.00598	CcSEcCtD
Orphenadrine—Vomiting—Erlotinib—kidney cancer	0.000795	0.00597	CcSEcCtD
Orphenadrine—Palpitations—Paclitaxel—kidney cancer	0.000787	0.00591	CcSEcCtD
Orphenadrine—Headache—Erlotinib—kidney cancer	0.000783	0.00588	CcSEcCtD
Orphenadrine—Constipation—Vincristine—kidney cancer	0.000783	0.00588	CcSEcCtD
Orphenadrine—Asthenia—Sunitinib—kidney cancer	0.000776	0.00583	CcSEcCtD
Orphenadrine—Nausea—Vinblastine—kidney cancer	0.000772	0.0058	CcSEcCtD
Orphenadrine—Somnolence—Gemcitabine—kidney cancer	0.000772	0.0058	CcSEcCtD
Orphenadrine—Nausea—Everolimus—kidney cancer	0.000769	0.00578	CcSEcCtD
Orphenadrine—Pruritus—Sunitinib—kidney cancer	0.000766	0.00575	CcSEcCtD
Orphenadrine—Hypersensitivity—Dactinomycin—kidney cancer	0.000755	0.00567	CcSEcCtD
Orphenadrine—Dizziness—Sorafenib—kidney cancer	0.000744	0.00559	CcSEcCtD
Orphenadrine—Constipation—Gemcitabine—kidney cancer	0.000742	0.00558	CcSEcCtD
Orphenadrine—Nausea—Erlotinib—kidney cancer	0.000742	0.00558	CcSEcCtD
Orphenadrine—Asthenia—Dactinomycin—kidney cancer	0.000735	0.00552	CcSEcCtD
Orphenadrine—Confusional state—Paclitaxel—kidney cancer	0.000733	0.00551	CcSEcCtD
Orphenadrine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000727	0.00546	CcSEcCtD
Orphenadrine—Dizziness—Sunitinib—kidney cancer	0.000715	0.00538	CcSEcCtD
Orphenadrine—Feeling abnormal—Gemcitabine—kidney cancer	0.000715	0.00538	CcSEcCtD
Orphenadrine—Vomiting—Sorafenib—kidney cancer	0.000715	0.00537	CcSEcCtD
Orphenadrine—Tachycardia—Paclitaxel—kidney cancer	0.000709	0.00533	CcSEcCtD
Orphenadrine—Skin disorder—Paclitaxel—kidney cancer	0.000706	0.00531	CcSEcCtD
Orphenadrine—Headache—Sorafenib—kidney cancer	0.000704	0.00529	CcSEcCtD
Orphenadrine—Vision blurred—Capecitabine—kidney cancer	0.000689	0.00518	CcSEcCtD
Orphenadrine—Vomiting—Sunitinib—kidney cancer	0.000688	0.00517	CcSEcCtD
Orphenadrine—Tremor—Capecitabine—kidney cancer	0.000685	0.00515	CcSEcCtD
Orphenadrine—Headache—Sunitinib—kidney cancer	0.000678	0.00509	CcSEcCtD
Orphenadrine—Hypersensitivity—Vincristine—kidney cancer	0.000674	0.00507	CcSEcCtD
Orphenadrine—Nausea—Sorafenib—kidney cancer	0.000668	0.00502	CcSEcCtD
Orphenadrine—Asthenia—Vincristine—kidney cancer	0.000657	0.00493	CcSEcCtD
Orphenadrine—Vomiting—Dactinomycin—kidney cancer	0.000651	0.00489	CcSEcCtD
Orphenadrine—Somnolence—Paclitaxel—kidney cancer	0.000646	0.00486	CcSEcCtD
Orphenadrine—Palpitations—Capecitabine—kidney cancer	0.000646	0.00485	CcSEcCtD
Orphenadrine—Nausea—Sunitinib—kidney cancer	0.000643	0.00483	CcSEcCtD
Orphenadrine—CYP2E1—urine—kidney cancer	0.000637	0.12	CbGeAlD
Orphenadrine—Asthenia—Gemcitabine—kidney cancer	0.000623	0.00468	CcSEcCtD
Orphenadrine—Constipation—Paclitaxel—kidney cancer	0.000622	0.00467	CcSEcCtD
Orphenadrine—Pruritus—Gemcitabine—kidney cancer	0.000614	0.00462	CcSEcCtD
Orphenadrine—Nausea—Dactinomycin—kidney cancer	0.000608	0.00457	CcSEcCtD
Orphenadrine—Dizziness—Vincristine—kidney cancer	0.000605	0.00455	CcSEcCtD
Orphenadrine—Drowsiness—Doxorubicin—kidney cancer	0.000603	0.00453	CcSEcCtD
Orphenadrine—Confusional state—Capecitabine—kidney cancer	0.000601	0.00452	CcSEcCtD
Orphenadrine—Feeling abnormal—Paclitaxel—kidney cancer	0.000599	0.0045	CcSEcCtD
Orphenadrine—Warfarin—CYP1A1—kidney cancer	0.000589	0.055	CrCbGaD
Orphenadrine—Tachycardia—Capecitabine—kidney cancer	0.000582	0.00438	CcSEcCtD
Orphenadrine—Vomiting—Vincristine—kidney cancer	0.000582	0.00437	CcSEcCtD
Orphenadrine—Skin disorder—Capecitabine—kidney cancer	0.000579	0.00435	CcSEcCtD
Orphenadrine—Urticaria—Paclitaxel—kidney cancer	0.000577	0.00434	CcSEcCtD
Orphenadrine—Headache—Vincristine—kidney cancer	0.000573	0.00431	CcSEcCtD
Orphenadrine—Vomiting—Gemcitabine—kidney cancer	0.000552	0.00415	CcSEcCtD
Orphenadrine—Reboxetine—ABCB1—kidney cancer	0.000547	0.0512	CrCbGaD
Orphenadrine—Headache—Gemcitabine—kidney cancer	0.000544	0.00409	CcSEcCtD
Orphenadrine—Nausea—Vincristine—kidney cancer	0.000544	0.00409	CcSEcCtD
Orphenadrine—Hypersensitivity—Paclitaxel—kidney cancer	0.000536	0.00402	CcSEcCtD
Orphenadrine—SCN9A—nephron tubule—kidney cancer	0.000523	0.0985	CbGeAlD
Orphenadrine—Asthenia—Paclitaxel—kidney cancer	0.000522	0.00392	CcSEcCtD
Orphenadrine—Nausea—Gemcitabine—kidney cancer	0.000516	0.00388	CcSEcCtD
Orphenadrine—Pruritus—Paclitaxel—kidney cancer	0.000514	0.00386	CcSEcCtD
Orphenadrine—CYP3A4—urine—kidney cancer	0.000512	0.0964	CbGeAlD
Orphenadrine—Constipation—Capecitabine—kidney cancer	0.00051	0.00383	CcSEcCtD
Orphenadrine—Feeling abnormal—Capecitabine—kidney cancer	0.000492	0.00369	CcSEcCtD
Orphenadrine—Fenoprofen—PTGS2—kidney cancer	0.000481	0.045	CrCbGaD
Orphenadrine—Dizziness—Paclitaxel—kidney cancer	0.000481	0.00361	CcSEcCtD
Orphenadrine—Urticaria—Capecitabine—kidney cancer	0.000474	0.00356	CcSEcCtD
Orphenadrine—Tension—Doxorubicin—kidney cancer	0.000462	0.00347	CcSEcCtD
Orphenadrine—Vomiting—Paclitaxel—kidney cancer	0.000462	0.00347	CcSEcCtD
Orphenadrine—Headache—Paclitaxel—kidney cancer	0.000455	0.00342	CcSEcCtD
Orphenadrine—Vision blurred—Doxorubicin—kidney cancer	0.000444	0.00334	CcSEcCtD
Orphenadrine—Hypersensitivity—Capecitabine—kidney cancer	0.000439	0.0033	CcSEcCtD
Orphenadrine—Toremifene—ABCB1—kidney cancer	0.000434	0.0406	CrCbGaD
Orphenadrine—Agitation—Doxorubicin—kidney cancer	0.000433	0.00325	CcSEcCtD
Orphenadrine—Nausea—Paclitaxel—kidney cancer	0.000432	0.00324	CcSEcCtD
Orphenadrine—Asthenia—Capecitabine—kidney cancer	0.000428	0.00322	CcSEcCtD
Orphenadrine—SCN4A—renal system—kidney cancer	0.000424	0.0798	CbGeAlD
Orphenadrine—Pruritus—Capecitabine—kidney cancer	0.000422	0.00317	CcSEcCtD
Orphenadrine—Palpitations—Doxorubicin—kidney cancer	0.000416	0.00313	CcSEcCtD
Orphenadrine—SCN4A—kidney—kidney cancer	0.00041	0.0772	CbGeAlD
Orphenadrine—SCN10A—nephron tubule—kidney cancer	0.000398	0.075	CbGeAlD
Orphenadrine—Dizziness—Capecitabine—kidney cancer	0.000394	0.00296	CcSEcCtD
Orphenadrine—Confusional state—Doxorubicin—kidney cancer	0.000388	0.00291	CcSEcCtD
Orphenadrine—Anaphylactic shock—Doxorubicin—kidney cancer	0.000385	0.00289	CcSEcCtD
Orphenadrine—Vomiting—Capecitabine—kidney cancer	0.000379	0.00285	CcSEcCtD
Orphenadrine—Tachycardia—Doxorubicin—kidney cancer	0.000375	0.00282	CcSEcCtD
Orphenadrine—Headache—Capecitabine—kidney cancer	0.000374	0.00281	CcSEcCtD
Orphenadrine—Skin disorder—Doxorubicin—kidney cancer	0.000373	0.00281	CcSEcCtD
Orphenadrine—Diphenhydramine—PTGS1—kidney cancer	0.000366	0.0342	CrCbGaD
Orphenadrine—Nausea—Capecitabine—kidney cancer	0.000354	0.00266	CcSEcCtD
Orphenadrine—Fluoxetine—ABCB1—kidney cancer	0.000343	0.0321	CrCbGaD
Orphenadrine—Somnolence—Doxorubicin—kidney cancer	0.000342	0.00257	CcSEcCtD
Orphenadrine—Constipation—Doxorubicin—kidney cancer	0.000329	0.00247	CcSEcCtD
Orphenadrine—Tamoxifen—CYP1A1—kidney cancer	0.000326	0.0305	CrCbGaD
Orphenadrine—Feeling abnormal—Doxorubicin—kidney cancer	0.000317	0.00238	CcSEcCtD
Orphenadrine—Urticaria—Doxorubicin—kidney cancer	0.000305	0.0023	CcSEcCtD
Orphenadrine—SCN5A—cardiac atrium—kidney cancer	0.000295	0.0555	CbGeAlD
Orphenadrine—Hypersensitivity—Doxorubicin—kidney cancer	0.000283	0.00213	CcSEcCtD
Orphenadrine—Asthenia—Doxorubicin—kidney cancer	0.000276	0.00207	CcSEcCtD
Orphenadrine—Pruritus—Doxorubicin—kidney cancer	0.000272	0.00204	CcSEcCtD
Orphenadrine—Dizziness—Doxorubicin—kidney cancer	0.000254	0.00191	CcSEcCtD
Orphenadrine—Vomiting—Doxorubicin—kidney cancer	0.000244	0.00184	CcSEcCtD
Orphenadrine—Headache—Doxorubicin—kidney cancer	0.000241	0.00181	CcSEcCtD
Orphenadrine—Nausea—Doxorubicin—kidney cancer	0.000228	0.00172	CcSEcCtD
Orphenadrine—KCNH2—renal system—kidney cancer	0.000202	0.0381	CbGeAlD
Orphenadrine—SLC6A2—gonad—kidney cancer	0.000202	0.038	CbGeAlD
Orphenadrine—CYP2B6—nephron tubule—kidney cancer	0.000183	0.0344	CbGeAlD
Orphenadrine—Trimipramine—ABCB1—kidney cancer	0.000181	0.0169	CrCbGaD
Orphenadrine—KCNH2—cardiac atrium—kidney cancer	0.000181	0.0341	CbGeAlD
Orphenadrine—Promethazine—ABCB1—kidney cancer	0.000175	0.0163	CrCbGaD
Orphenadrine—Tamoxifen—ABCB1—kidney cancer	0.000173	0.0162	CrCbGaD
Orphenadrine—Doxepin—ABCB1—kidney cancer	0.000173	0.0162	CrCbGaD
Orphenadrine—Methadone—ABCB1—kidney cancer	0.000172	0.0161	CrCbGaD
Orphenadrine—CYP2E1—nephron tubule—kidney cancer	0.000171	0.0323	CbGeAlD
Orphenadrine—CYP2B6—renal system—kidney cancer	0.000166	0.0313	CbGeAlD
Orphenadrine—CYP2B6—kidney—kidney cancer	0.00016	0.0302	CbGeAlD
Orphenadrine—CYP2E1—renal system—kidney cancer	0.000156	0.0293	CbGeAlD
Orphenadrine—CYP2E1—kidney—kidney cancer	0.000151	0.0284	CbGeAlD
Orphenadrine—CYP2B6—gonad—kidney cancer	0.000149	0.028	CbGeAlD
Orphenadrine—CYP2E1—cortex of kidney—kidney cancer	0.000147	0.0276	CbGeAlD
Orphenadrine—Imipramine—ABCB1—kidney cancer	0.000134	0.0126	CrCbGaD
Orphenadrine—Amitriptyline—ABCB1—kidney cancer	0.000134	0.0125	CrCbGaD
Orphenadrine—CYP3A4—renal system—kidney cancer	0.000125	0.0236	CbGeAlD
Orphenadrine—CYP3A4—kidney—kidney cancer	0.000121	0.0228	CbGeAlD
Orphenadrine—SCN5A—Axon guidance—MAPK3—kidney cancer	7.86e-05	0.000285	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—AKAP13—kidney cancer	7.85e-05	0.000284	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—CTNNB1—kidney cancer	7.84e-05	0.000284	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—RAF1—kidney cancer	7.79e-05	0.000282	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—RELA—kidney cancer	7.75e-05	0.00028	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—ERBB2—kidney cancer	7.7e-05	0.000279	CbGpPWpGaD
Orphenadrine—CHRM2—SIDS Susceptibility Pathways—VEGFA—kidney cancer	7.69e-05	0.000278	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—MAPK1—kidney cancer	7.6e-05	0.000275	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—MAPK1—kidney cancer	7.6e-05	0.000275	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—MAPK3—kidney cancer	7.55e-05	0.000273	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—MAPK1—kidney cancer	7.48e-05	0.000271	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—APRT—kidney cancer	7.48e-05	0.000271	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—FH—kidney cancer	7.48e-05	0.000271	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—ITPR2—kidney cancer	7.47e-05	0.00027	CbGpPWpGaD
Orphenadrine—SCN4A—Developmental Biology—KRAS—kidney cancer	7.44e-05	0.000269	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—ITPR2—kidney cancer	7.35e-05	0.000266	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—APRT—kidney cancer	7.33e-05	0.000265	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—FH—kidney cancer	7.33e-05	0.000265	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—kidney cancer	7.19e-05	0.00026	CbGpPWpGaD
Orphenadrine—SCN1A—Developmental Biology—KRAS—kidney cancer	7.17e-05	0.00026	CbGpPWpGaD
Orphenadrine—SCN10A—Developmental Biology—KRAS—kidney cancer	7.17e-05	0.00026	CbGpPWpGaD
Orphenadrine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	7.13e-05	0.000258	CbGpPWpGaD
Orphenadrine—SCN5A—Axon guidance—KRAS—kidney cancer	7.07e-05	0.000256	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GPC3—kidney cancer	7.03e-05	0.000255	CbGpPWpGaD
Orphenadrine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	7.02e-05	0.000254	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—VEGFA—kidney cancer	6.9e-05	0.00025	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GPC3—kidney cancer	6.89e-05	0.000249	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—GSTP1—kidney cancer	6.88e-05	0.000249	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GPC3—kidney cancer	6.88e-05	0.000249	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CER1—kidney cancer	6.88e-05	0.000249	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CA2—kidney cancer	6.84e-05	0.000248	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	6.79e-05	0.000246	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—ITPR2—kidney cancer	6.79e-05	0.000246	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—KRAS—kidney cancer	6.79e-05	0.000246	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GPC3—kidney cancer	6.77e-05	0.000245	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CER1—kidney cancer	6.77e-05	0.000245	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—CTNNB1—kidney cancer	6.74e-05	0.000244	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CA2—kidney cancer	6.7e-05	0.000243	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—ITPR2—kidney cancer	6.68e-05	0.000242	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ALAD—kidney cancer	6.67e-05	0.000241	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ALAD—kidney cancer	6.53e-05	0.000236	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—MAPK3—kidney cancer	6.53e-05	0.000236	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ST3GAL2—kidney cancer	6.51e-05	0.000235	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ST3GAL2—kidney cancer	6.37e-05	0.000231	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ALDH1A1—kidney cancer	6.36e-05	0.00023	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—GSTM1—kidney cancer	6.33e-05	0.000229	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—ANXA1—kidney cancer	6.26e-05	0.000227	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	6.24e-05	0.000226	CbGpPWpGaD
Orphenadrine—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—kidney cancer	6.24e-05	0.000226	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ALDH1A1—kidney cancer	6.23e-05	0.000225	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—MAPK1—kidney cancer	6.21e-05	0.000225	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—ANXA1—kidney cancer	6.16e-05	0.000223	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PGK1—kidney cancer	6.1e-05	0.000221	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—SLC5A3—kidney cancer	6.1e-05	0.000221	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	6e-05	0.000217	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—LDHB—kidney cancer	5.98e-05	0.000216	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PGK1—kidney cancer	5.97e-05	0.000216	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—SLC5A3—kidney cancer	5.97e-05	0.000216	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—VEGFA—kidney cancer	5.93e-05	0.000215	CbGpPWpGaD
Orphenadrine—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	5.91e-05	0.000214	CbGpPWpGaD
Orphenadrine—GRIN1—Developmental Biology—KRAS—kidney cancer	5.87e-05	0.000212	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—LDHB—kidney cancer	5.86e-05	0.000212	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—SFRP2—kidney cancer	5.85e-05	0.000212	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—SFRP2—kidney cancer	5.76e-05	0.000208	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	5.72e-05	0.000207	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—ANXA1—kidney cancer	5.69e-05	0.000206	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—MAPK3—kidney cancer	5.61e-05	0.000203	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—ANXA1—kidney cancer	5.6e-05	0.000203	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	5.45e-05	0.000197	CbGpPWpGaD
Orphenadrine—HRH1—GPCR ligand binding—POMC—kidney cancer	5.43e-05	0.000196	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR ligand binding—POMC—kidney cancer	5.34e-05	0.000193	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—MAPK1—kidney cancer	5.34e-05	0.000193	CbGpPWpGaD
Orphenadrine—HRH1—G alpha (q) signalling events—PIK3CA—kidney cancer	5.28e-05	0.000191	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ACY1—kidney cancer	5.28e-05	0.000191	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CA9—kidney cancer	5.19e-05	0.000188	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	5.14e-05	0.000186	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CA9—kidney cancer	5.08e-05	0.000184	CbGpPWpGaD
Orphenadrine—SCN5A—Developmental Biology—KRAS—kidney cancer	5.04e-05	0.000183	CbGpPWpGaD
Orphenadrine—SLC6A2—Transmembrane transport of small molecules—RAF1—kidney cancer	4.96e-05	0.00018	CbGpPWpGaD
Orphenadrine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	4.73e-05	0.000171	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—AKAP13—kidney cancer	4.72e-05	0.000171	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CASP2—kidney cancer	4.72e-05	0.000171	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—AKAP13—kidney cancer	4.64e-05	0.000168	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CASP2—kidney cancer	4.64e-05	0.000168	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PDHB—kidney cancer	4.49e-05	0.000162	CbGpPWpGaD
Orphenadrine—CYP3A4—Biological oxidations—POMC—kidney cancer	4.47e-05	0.000162	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CRABP1—kidney cancer	4.41e-05	0.00016	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CRABP1—kidney cancer	4.32e-05	0.000156	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—GRB7—kidney cancer	4.31e-05	0.000156	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—GRB7—kidney cancer	4.24e-05	0.000154	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CCBL1—kidney cancer	4.22e-05	0.000153	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ITPR2—kidney cancer	4.1e-05	0.000148	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ITPR2—kidney cancer	4.01e-05	0.000145	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ITPR2—kidney cancer	4.01e-05	0.000145	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ITPR2—kidney cancer	3.95e-05	0.000143	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ACHE—kidney cancer	3.74e-05	0.000135	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GSTT1—kidney cancer	3.74e-05	0.000135	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ACHE—kidney cancer	3.66e-05	0.000132	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GSTT1—kidney cancer	3.66e-05	0.000132	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PPAT—kidney cancer	3.66e-05	0.000132	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GLIPR1—kidney cancer	3.66e-05	0.000132	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CTNNA1—kidney cancer	3.64e-05	0.000132	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HSPB1—kidney cancer	3.61e-05	0.000131	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—EIF4EBP1—kidney cancer	3.61e-05	0.000131	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CTNNA1—kidney cancer	3.58e-05	0.000129	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—EIF4EBP1—kidney cancer	3.56e-05	0.000129	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HSPB1—kidney cancer	3.56e-05	0.000129	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—SCARB1—kidney cancer	3.54e-05	0.000128	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PTGS1—kidney cancer	3.5e-05	0.000127	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—SCARB1—kidney cancer	3.47e-05	0.000125	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PSMD7—kidney cancer	3.43e-05	0.000124	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PTGS1—kidney cancer	3.43e-05	0.000124	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—APRT—kidney cancer	3.4e-05	0.000123	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—FH—kidney cancer	3.4e-05	0.000123	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PSMD7—kidney cancer	3.36e-05	0.000122	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PSMD7—kidney cancer	3.36e-05	0.000122	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ANXA1—kidney cancer	3.36e-05	0.000122	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TSC1—kidney cancer	3.36e-05	0.000122	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TSC1—kidney cancer	3.31e-05	0.00012	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PSMD7—kidney cancer	3.31e-05	0.00012	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ANXA1—kidney cancer	3.31e-05	0.00012	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—BCHE—kidney cancer	3.26e-05	0.000118	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—FLT1—kidney cancer	3.25e-05	0.000118	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—SLC5A5—kidney cancer	3.22e-05	0.000116	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—FLT1—kidney cancer	3.2e-05	0.000116	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GPC3—kidney cancer	3.2e-05	0.000116	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—BCHE—kidney cancer	3.19e-05	0.000115	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—SLC5A5—kidney cancer	3.15e-05	0.000114	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CA2—kidney cancer	3.11e-05	0.000113	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—SLC2A1—kidney cancer	3.11e-05	0.000112	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—POMC—kidney cancer	3.07e-05	0.000111	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—SLC2A1—kidney cancer	3.04e-05	0.00011	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALAD—kidney cancer	3.03e-05	0.00011	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—POMC—kidney cancer	3.02e-05	0.000109	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PAK1—kidney cancer	3.02e-05	0.000109	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—JUNB—kidney cancer	3.02e-05	0.000109	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—JUNB—kidney cancer	2.97e-05	0.000107	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PAK1—kidney cancer	2.97e-05	0.000107	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.96e-05	0.000107	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.89e-05	0.000105	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—POMC—kidney cancer	2.79e-05	0.000101	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PGK1—kidney cancer	2.77e-05	0.0001	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.77e-05	0.0001	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—POMC—kidney cancer	2.74e-05	9.92e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—LDHB—kidney cancer	2.72e-05	9.83e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GSTP1—kidney cancer	2.59e-05	9.38e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GSTP1—kidney cancer	2.54e-05	9.18e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IGF2—kidney cancer	2.47e-05	8.92e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CDKN2B—kidney cancer	2.46e-05	8.89e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—ABCB1—kidney cancer	2.45e-05	8.87e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IGF2—kidney cancer	2.43e-05	8.78e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CDKN2B—kidney cancer	2.42e-05	8.74e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—ABCB1—kidney cancer	2.4e-05	8.69e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IGF1R—kidney cancer	2.38e-05	8.63e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—GSTM1—kidney cancer	2.38e-05	8.62e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CA9—kidney cancer	2.36e-05	8.53e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IGF1R—kidney cancer	2.35e-05	8.49e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—GSTM1—kidney cancer	2.33e-05	8.44e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—RAF1—kidney cancer	2.3e-05	8.31e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—IL2—kidney cancer	2.27e-05	8.21e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—RAF1—kidney cancer	2.26e-05	8.18e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—CYP1A1—kidney cancer	2.26e-05	8.17e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—IL2—kidney cancer	2.23e-05	8.08e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—CYP1A1—kidney cancer	2.21e-05	8e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—IL2—kidney cancer	2.06e-05	7.45e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—IL2—kidney cancer	2.03e-05	7.34e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CRABP1—kidney cancer	2e-05	7.25e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—HIF1A—kidney cancer	1.96e-05	7.1e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TSC2—kidney cancer	1.96e-05	7.09e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—HIF1A—kidney cancer	1.93e-05	6.99e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TSC2—kidney cancer	1.93e-05	6.97e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KDR—kidney cancer	1.88e-05	6.79e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ITPR2—kidney cancer	1.86e-05	6.74e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KDR—kidney cancer	1.85e-05	6.68e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—APC—kidney cancer	1.73e-05	6.26e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KIT—kidney cancer	1.73e-05	6.26e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—APC—kidney cancer	1.7e-05	6.16e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KIT—kidney cancer	1.7e-05	6.16e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ACHE—kidney cancer	1.7e-05	6.15e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTT1—kidney cancer	1.7e-05	6.15e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—POMC—kidney cancer	1.68e-05	6.09e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—MAPK3—kidney cancer	1.66e-05	5.99e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—POMC—kidney cancer	1.65e-05	5.96e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—POMC—kidney cancer	1.65e-05	5.96e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—MAPK3—kidney cancer	1.63e-05	5.9e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—BRAF—kidney cancer	1.63e-05	5.88e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—POMC—kidney cancer	1.62e-05	5.86e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SCARB1—kidney cancer	1.61e-05	5.82e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—BRAF—kidney cancer	1.6e-05	5.79e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTGS1—kidney cancer	1.59e-05	5.76e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—MAPK1—kidney cancer	1.58e-05	5.7e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PSMD7—kidney cancer	1.56e-05	5.65e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—MAPK1—kidney cancer	1.55e-05	5.61e-05	CbGpPWpGaD
Orphenadrine—HRH1—GPCR downstream signaling—PIK3CA—kidney cancer	1.51e-05	5.45e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—KRAS—kidney cancer	1.49e-05	5.39e-05	CbGpPWpGaD
Orphenadrine—CHRM2—GPCR downstream signaling—PIK3CA—kidney cancer	1.48e-05	5.36e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—BCHE—kidney cancer	1.48e-05	5.35e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—KRAS—kidney cancer	1.46e-05	5.3e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.46e-05	5.29e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.41e-05	5.11e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling by GPCR—PIK3CA—kidney cancer	1.37e-05	4.95e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—RAF1—kidney cancer	1.36e-05	4.91e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—RELA—kidney cancer	1.35e-05	4.89e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	1.35e-05	4.87e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—ERBB2—kidney cancer	1.34e-05	4.86e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PTGS2—kidney cancer	1.34e-05	4.86e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—RAF1—kidney cancer	1.34e-05	4.83e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—RELA—kidney cancer	1.33e-05	4.81e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MTOR—kidney cancer	1.33e-05	4.8e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—ERBB2—kidney cancer	1.32e-05	4.78e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PTGS2—kidney cancer	1.31e-05	4.76e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MTOR—kidney cancer	1.3e-05	4.72e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CDKN1B—kidney cancer	1.24e-05	4.5e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	1.22e-05	4.43e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—IL2—kidney cancer	1.22e-05	4.4e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—IL2—kidney cancer	1.2e-05	4.33e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CCND1—kidney cancer	1.19e-05	4.29e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—JUN—kidney cancer	1.18e-05	4.28e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTP1—kidney cancer	1.18e-05	4.26e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—CTNNB1—kidney cancer	1.17e-05	4.25e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PTEN—kidney cancer	1.17e-05	4.24e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CCND1—kidney cancer	1.17e-05	4.22e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—JUN—kidney cancer	1.16e-05	4.22e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	1.16e-05	4.18e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PTEN—kidney cancer	1.15e-05	4.15e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PTEN—kidney cancer	1.15e-05	4.14e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PTEN—kidney cancer	1.13e-05	4.08e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—ABCB1—kidney cancer	1.11e-05	4.03e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—GSTM1—kidney cancer	1.08e-05	3.91e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—VEGFA—kidney cancer	1.03e-05	3.74e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.03e-05	3.71e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—VEGFA—kidney cancer	1.02e-05	3.68e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MAPK3—kidney cancer	9.78e-06	3.54e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MAPK3—kidney cancer	9.63e-06	3.48e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MYC—kidney cancer	9.52e-06	3.44e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MYC—kidney cancer	9.36e-06	3.39e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—MAPK1—kidney cancer	9.31e-06	3.37e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—MAPK1—kidney cancer	9.16e-06	3.31e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—KRAS—kidney cancer	8.79e-06	3.18e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—KRAS—kidney cancer	8.65e-06	3.13e-05	CbGpPWpGaD
Orphenadrine—CYP2B6—Metabolism—PIK3CA—kidney cancer	8.26e-06	2.99e-05	CbGpPWpGaD
Orphenadrine—CYP2E1—Metabolism—PIK3CA—kidney cancer	8.09e-06	2.93e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—PIK3CA—kidney cancer	8.08e-06	2.92e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	7.95e-06	2.88e-05	CbGpPWpGaD
Orphenadrine—HRH1—Signaling Pathways—TP53—kidney cancer	7.81e-06	2.83e-05	CbGpPWpGaD
Orphenadrine—CHRM2—Signaling Pathways—TP53—kidney cancer	7.69e-06	2.78e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—POMC—kidney cancer	7.65e-06	2.77e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTGS2—kidney cancer	6.1e-06	2.21e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PTEN—kidney cancer	5.32e-06	1.92e-05	CbGpPWpGaD
Orphenadrine—CYP3A4—Metabolism—PIK3CA—kidney cancer	3.75e-06	1.36e-05	CbGpPWpGaD
